Mint Tower Capital Management
APLS icon

Mint Tower Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Mint Tower Capital Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,000
Closed -$885K – 346
2026
Q1 		$885K Buy
+22,000
New +$474K 0.08% 192

Other funds holding APLS

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Mint Tower Capital Management's APLS Position: Q2 2026 in Review

Mint Tower Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 22,000 shares — an estimated $885K sold.

Mint Tower Capital Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $885K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Mint Tower Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Mint Tower Capital Management sold 22,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $885K.
  • Mint Tower Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Mint Tower Capital Management's Apellis Pharmaceuticals position peaked at $885K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Mint Tower Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.